{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:39:59Z","timestamp":1753889999821,"version":"3.41.2"},"reference-count":38,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Schol Ed)"],"abstract":"<jats:p>Background: Metachromatic leukodystrophy (MLD) is an autosomal recessive hereditary neurodegenerative disease caused by a deficiency in arylsulfatase A (ARSA) activity and belongs to the group of lysosomal storage diseases. A biochemical diagnosis of MLD is based on determining the residual ARSA activity in leukocytes, skin fibroblasts, and urine. This study documents our biochemical experience and estimates the relative frequency of MLD over 21 years (2001\u20132022). Methods: This study analyzed 4357 suspected cases of MLD in Egypt. The ARSA activity was spectrophotometrically determined in leukocytes in all the referred cases. Results: Of these 4357 referred cases, 577 (13%) possessed decreased ARSA activity, less than 10% of the low normal range (50\u2013200 micromole\/gram protein\/hour (\u03bcmol\/g protein\/h), and 104 cases were diagnosed as having a pseudodeficiency in enzyme activity (&lt;20\u201350% of low\u2013normal ARSA activity). The prevalence of MLD was 1.6\/100,000. Conclusions: A diagnosis of MLD in Egypt is based on enzyme activity levels and clinical suspicion; molecular analysis was performed in a few cases.<\/jats:p>","DOI":"10.31083\/j.fbs1604020","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:13:11Z","timestamp":1735560791000},"source":"Crossref","is-referenced-by-count":1,"title":["Relative Frequency of Metachromatic Leukodystrophy in Egypt: A Reference Laboratory Report"],"prefix":"10.31083","volume":"16","author":[{"given":"Ekram","family":"Fateen","sequence":"first","affiliation":[{"name":"Biochemical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, 12622 Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2621-6059","authenticated-orcid":true,"given":"Zeinab Y.","family":"Abdallah","sequence":"first","affiliation":[{"name":"Biochemical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, 12622 Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Shaimardanova AA, Chulpanova DS, Solovyeva VV, Mullagulova AI, Kitaeva KV, Allegrucci C, et al. Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches. Frontiers in Medicine. 2020; 7: 576221.","DOI":"10.3389\/fmed.2020.576221"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Cesani M, Lorioli L, Grossi S, Amico G, Fumagalli F, Spiga I, et al. Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy. Human Mutation. 2016; 37: 16\u201327.","DOI":"10.1002\/humu.22919"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kehrer C, Elg\u00fcn S, Raabe C, B\u00f6hringer J, Beck-W\u00f6dl S, Bevot A, et al. Association of Age at Onset and First Symptoms with Disease Progression in Patients with Metachromatic Leukodystrophy. Neurology. 2021; 96: e255\u2013e266.","DOI":"10.1212\/WNL.0000000000011047"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Practice & Research. Clinical Endocrinology & Metabolism. 2015; 29: 261\u2013273.","DOI":"10.1016\/j.beem.2014.10.001"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Beerepoot S, Nierkens S, Boelens JJ, Lindemans C, Bugiani M, Wolf NI. Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective. Orphanet Journal of Rare Diseases. 2019; 14: 240.","DOI":"10.1186\/s13023-019-1220-4"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Borges FM, Costa MJGD, Carneiro ZA, Louren\u00e7o CM. Metachromatic leukodystrophy: pediatric presentation and the challenges of early diagnosis. Revista Da Associacao Medica Brasileira (1992). 2020; 66: 1344\u20131350.","DOI":"10.1590\/1806-9282.66.10.1344"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"van Rappard DF, Klauser A, Steenweg ME, Boelens JJ, Bugiani M, van der Knaap MS, et al. Quantitative MR spectroscopic imaging in metachromatic leukodystrophy: value for prognosis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry. 2018; 89: 105\u2013111.","DOI":"10.1136\/jnnp-2017-316364"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Skoog WA, Beck WS. Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood. 1956; 11: 436\u2013454.","DOI":"10.1182\/blood.V11.5.436.436"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry. 1951; 193: 265\u2013275.","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"ref10","unstructured":"Wenger DA, Williams C. Screening for lysosomal disorders. In Hommes FA (ed.) Techniques in Diagnostic Human Bio-chemical Genetics (pp. 587\u2013617). Wiley-Liss: New York. 1991."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Amr K, Fateen E, Mansour L, Tosson AM, Zaki MS, Salam GMA, et al. Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum. Journal of Molecular Neuroscience: MN. 2021; 71: 1112\u20131130.","DOI":"10.1007\/s12031-020-01734-1"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Shawky RM, El-Awady MY, Elsayed SM, Hamadan GE. Consanguineous matings among Egyptian population. Egyptian Journal of Medical Human Genetics. 2001; 12: 157\u2013163.","DOI":"10.1016\/j.ejmhg.2011.07.001"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Temtamy SA, Aglan MS, Meguid NA. Genetic disorders in the Egyptians. In Teebi AS (ed.) Genetic Disorders Among Arab Population. Springer: Heidelberg, Germany. 2010.","DOI":"10.1007\/978-3-642-05080-0_8"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Fateen E, Abdallah ZY. Twenty-five years of biochemical diagnosis of Gaucher disease: the Egyptian experience. Heliyon. 2019; 5: e02574.","DOI":"10.1016\/j.heliyon.2019.e02574"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Fahmy EM, Abdelkreem E, Mohamed OE, Abosdera MM, Sadek AA. Characterization of 42 Egyptian Children with Lysosomal Storage Disorders. The Egyptian Journal of Hospital Medicine. 2022; 88: 3069\u20133077.","DOI":"10.21608\/ejhm.2022.244542"},{"key":"ref16","unstructured":"Jabbehdari S, Rahimian E, Jafari N, Sanii S, Khayatzadehkakhki S, Nejad Biglari H. The clinical features and diagnosis of Metachromatic leukodystrophy: A case series of Iranian Pediatric Patients. Iranian Journal of Child Neurology. 2015; 9: 57\u201361."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Narayanan DL, Matta D, Gupta N, Kabra M, Ranganath P, Aggarwal S, et al. Spectrum of ARSA variations in Asian Indian patients with Arylsulfatase A deficient metachromatic leukodystrophy. Journal of Human Genetics. 2019; 64: 323\u2013331.","DOI":"10.1038\/s10038-019-0560-1"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Alfadhel M, Almuqbil M, Al Mutairi F, Umair M, Almannai M, Alghamdi M, et al. The Leukodystrophy Spectrum in Saudi Arabia: Epidemiological, Clinical, Radiological, and Genetic Data. Frontiers in Pediatrics. 2021; 9: 633385.","DOI":"10.3389\/fped.2021.633385"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Fateen E, Abdallah ZY, Nazim WS, Ibrahim M, Radwan A. Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt. Heliyon. 2021; 7: e07830.","DOI":"10.1016\/j.heliyon.2021.e07830"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Santhanakumaran V, Groeschel S, Harzer K, Kehrer C, Elg\u00fcn S, Beck-W\u00f6dl S, et al. Predicting clinical phenotypes of metachromatic leukodystrophy based on the arylsulfatase A activity and the ARSA genotype? - Chances and challenges. Molecular Genetics and Metabolism. 2022; 137: 273\u2013282.","DOI":"10.1016\/j.ymgme.2022.09.009"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"K\u00f6hler W, Curiel J, Vanderver A. Adulthood leukodystrophies. Nature Reviews. Neurology. 2018; 14: 94\u2013105.","DOI":"10.1038\/nrneurol.2017.175"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Raina A, Nair SS, Nagesh C, Thomas B, Nair M, Sundaram S. Electroneurography and Advanced Neuroimaging Profile in Pediatric-onset Metachromatic Leukodystrophy. Journal of Pediatric Neurosciences. 2019; 14: 70\u201375.","DOI":"10.4103\/jpn.JPN_155_18"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Chen L, Yan H, Cao B, Wu Y, Gu Q, Xiao J, et al. Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy. International Journal of Genomics. 2018; 2018: 2361068.","DOI":"10.1155\/2018\/2361068"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Pekg\u00fcl F, Ero\u011flu-Ertu\u011frul NG, Bekircan-Kurt CE, Erdem-Ozdamar S, \u00c7etinkaya A, Tan E, et al. Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives. Molecular Genetics and Metabolism Reports. 2020; 25: 100688.","DOI":"10.1016\/j.ymgmr.2020.100688"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Wang RY, Bodamer OA, Watson MS, Wilcox WR, ACMG Work Group on Diagnostic Confirmation of Lysosomal Storage Diseases. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genetics in Medicine: Official Journal of the American College of Medical Genetics. 2011; 13: 457\u2013484.","DOI":"10.1097\/GIM.0b013e318211a7e1"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"B\u00f6hringer J, Santer R, Schumacher N, Gieseke F, Cornils K, Pechan M, et al. Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells. Human Mutation. 2017; 38: 1511\u20131520.","DOI":"10.1002\/humu.23306"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Elg\u00fcn S, Waibel J, Kehrer C, van Rappard D, B\u00f6hringer J, Beck-W\u00f6dl S, et al. Phenotypic variation between siblings with Metachromatic Leukodystrophy. Orphanet Journal of Rare Diseases. 2019; 14: 136.","DOI":"10.1186\/s13023-019-1113-6"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Harrington M, Whalley D, Twiss J, Rushton R, Martin S, Huynh L, et al. Insights into the natural history of metachromatic leukodystrophy from interviews with caregivers. Orphanet Journal of Rare Diseases. 2019; 14: 89.","DOI":"10.1186\/s13023-019-1060-2"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Gieselmann V, Wenger DA, Kr\u00e4geloh-Mann I. Metachromatic Leukodystrophy and Globoid Cell Leukodystrophy. In Mehta AB, Winchester B (eds.) John Wiley & Sons, Ltd.: UK. 2022.","DOI":"10.1002\/9781119697312.ch12"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Doherty K, Frazier SB, Clark M, Childers A, Pruthi S, Wenger DA, et al. A closer look at ARSA activity in a patient with metachromatic leukodystrophy. Molecular Genetics and Metabolism Reports. 2019; 19: 100460.","DOI":"10.1016\/j.ymgmr.2019.100460"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Angelopoulou E, Paudel YN, Villa C, Piperi C. Arylsulfatase A (ASA) in Parkinson\u2019s Disease: From Pathogenesis to Biomarker Potential. Brain Sciences. 2020; 10: 713.","DOI":"10.3390\/brainsci10100713"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Shen N, Li ZG, Waye JS, Francis G, Chang PL. Complications in the genotypic molecular diagnosis of pseudo arylsulfatase A deficiency. American Journal of Medical Genetics. 1993; 45: 631\u2013637.","DOI":"10.1002\/ajmg.1320450523"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Ben Halim N, Dorboz I, Kefi R, Kharrat N, Eymard-Pierre E, Nagara M, et al. Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2016; 37: 403\u2013409.","DOI":"10.1007\/s10072-015-2417-5"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Ju\u00e1rez-Osuna JA, Mendoza-Ruvalcaba SC, Porras-Dorantes A, Da Silva-Jos\u00e9 TD, Garc\u00eda-Ortiz JE. Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis. Molecular Genetics & Genomic Medicine. 2020; 8: e1305.","DOI":"10.1002\/mgg3.1305"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Chab\u00e1s A, Castellvi S, Bay\u00e9s M, Balcells S, Grinberg D, Vilageliu L, et al. Frequency of the arylsulphatase A pseudodeficiency allele in the Spanish population. Clinical Genetics. 1993; 44: 320\u2013323.","DOI":"10.1111\/j.1399-0004.1993.tb03908.x"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Pedron CG, Gaspar PA, Giugliani R, Pereira ML. Arylsulfatase A pseudodeficiency in healthy Brazilian individuals. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 1999; 32: 941\u2013945.","DOI":"10.1590\/s0100-879x1999000800002"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. The frequency of lysosomal storage diseases in The Netherlands. Human Genetics. 1999; 105: 151\u2013156.","DOI":"10.1007\/s004399900075"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Al-Ghanim KA. Consanguineous marriage in the Arab societies. Journal of Psychology & Clinical Psychiatry. 2020; 11: 166\u2012168. http:\/\/dx.doi.org\/","DOI":"10.15406\/jpcpy.2020.11.00692"}],"container-title":["Frontiers in Bioscience-Scholar"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBS\/16\/4\/10.31083\/j.fbs1604020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:15:53Z","timestamp":1735560953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBS\/16\/4\/10.31083\/j.fbs1604020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["S1945-0516(24)00117-5"],"URL":"https:\/\/doi.org\/10.31083\/j.fbs1604020","relation":{},"ISSN":["1945-0516","1945-0524"],"issn-type":[{"type":"print","value":"1945-0516"},{"type":"electronic","value":"1945-0524"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"article-number":"20"}}